Semaglutide 0.75mg (Weekly injections X 4) Gallery
$$MultiPurposeText$$
See examples of our Semaglutide 0.75mg (Weekly injections X 4) work and results.
What Our Clients Say
$$MultiPurposeText$$
Read testimonials from our satisfied customers
Great experience with doctor.
I got Great results with weight loss.
Reception was courteou...more
...more
Frequently Asked Questions
Get answers to common questions about Semaglutide 0.75mg (Weekly injections X 4).
Many patients notice reduced appetite and smaller portion sizes within one to two weeks; measurable weight change often appears during the four-week protocol but meaningful, sustained weight loss typically requires ongoing treatment plus lifestyle adjustments and close clinical follow-up.
Common side effects include nausea, vomiting, constipation, diarrhea and mild abdominal discomfort; these are usually transient and dose-related. Stay hydrated, follow dietary advice, and contact our clinic promptly if symptoms persist, worsen, or you experience severe reactions.
Not everyone is a candidate. It's contraindicated in pregnancy, breastfeeding, personal or family history of medullary thyroid carcinoma or pancreatitis, and some medications interact. Our clinicians evaluate medical history, labs, and current medications to determine safety and suitability before treatment.
Some interactions are possible, especially with diabetes medications that can cause low blood sugar. Inform clinicians about all prescription drugs, over-the-counter medicines, and supplements so we can review interactions, adjust dosing if necessary, and monitor you closely during the four-week protocol.
Prepare by attending an initial consultation, completing recommended labs, and reviewing medical history and medications. Plan meals and hydration strategies, receive injection training from staff, and arrange follow-up appointments to report progress and manage potential side effects during the month.
Yes—continuation depends on clinical response, tolerability, and goals. Our team reviews outcomes and labs after the four-week protocol to decide whether to maintain, escalate, or modify therapy. Continued treatment is personalized, with ongoing monitoring to ensure safety and effectiveness.